Serum Institute joins hands with IAVI, Merck to develop coronavirus neutralising antibodies


Content Team
Image Credit: Shortpedia

Serum Institute of India and the International AIDS Vaccine Initiative have joined hands with American pharmaceutical giant Merck to develop coronavirus neutralising monoclonal antibodies. The antibodies will neutralise SARS-CoV-2, the virus that causes coronavirus disease. Non-profit organisation IAVI and Scripps Research, a non-profit American biomedical research facility, have jointly invented the antibodies.